Better Long-Term Buy: Eli Lilly or Viking Therapeutics?

Better Long-Term Buy: Eli Lilly or Viking Therapeutics?

Key PointsEli Lilly has been a growth beast, coming off an impressive year in which its revenue rose by 45%.Viking Therapeutics has an exciting GLP-1 drug in development that, if approved, could send its shares skyrocketing.10 stocks we like better than Eli Lilly › Billionaire investor Warren Buffett has said in the past that "the stock market is a device for transferring money from the impatient to the patient." While it's easy to get caught up…